Journal Mobile Options
Table of Contents
Vol. 74, No. 1, 2006
Issue release date: November 2006

Food Allergies and Eosinophilic Esophagitis – Two Case Studies

Martín-Muñoz M.F. · Lucendo A.J. · Navarro M. · Letrán A. · Martín-Chávarri S. · Burgos E. · Martín-Esteban M.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Eosinophilic esophagitis (EE) is a clinical-pathological disorder which is being increasingly diagnosed. It is etiologically associated with hypersensitivity to airborne allergens and/or dietary components. However, immediate hypersensitivity to foods has rarely been proven as the etiologic cause of the disorder. Two patients are presented with a history of rhinoconjunctivitis, allergic asthma, atopic dermatitis and food allergies which are currently under control and who show specific IgE to pulses and chicken respectively. These patients developed acute dysphagia and vomiting immediately after ingesting these foods and following appropriate examination were diagnosed as suffering from EE. The study also showed signs of blood hypereosinophilia while the esophageal manometry revealed a motor disorder characterized by aperistalsis and non-propulsive simultaneous waves affecting the lower two-thirds of the organ composed of smooth muscle. Topical treatment with fluticasone propionate was administered over a period of 3 months, in addition to a diet abstaining from the aforementioned foods and this led to remission of dysphagia and normalization of the endoscopic, histological and manometric studies of the esophagus. This situation remained stable for a considerable length of time after steroid treatment was discontinued, which showed that exposure to foods seemed to be the cause of the esophageal disorder. Similarly, allergies to inhalants and other digestive symptoms which appear upon immediate ingestion of the foods involved would not justify the sudden onset of dysphagia. We offer a pathophysiological explanation for the mechanisms of the disease based on the activation of eosinophils and mast cells by IgE and their ability to disturb the dynamic behavior of the neural and muscle components of the esophageal wall.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Attwood S, Smyrk TC, Demeester TR, Jones JB: Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993;38:109–116.
  2. Spergel JM, Beausoleil JL, Mascareñas M, Liacouras CA: The use of skin prick test and patch test to identify causative foods in eosinophilic esophagitis. J Allergy Clin Inmunol 2002;109:363–368.
  3. Fox V, Nurko S, Furuta G: Eosinophilic esophagitis: it’s not just kid’s stuff. Gastrointest Endosc 2002;56:260–270.
  4. Faubion WA, Perrault J, Burgart LJ, Zein NN, Clawson ML, Freese DK: Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998;27:90–93.
  5. Sondheimer JM: What are the roles of eosinophils in esophagitis? J Pediatr Gastroenterol Nutr 1998;27:118–119.
  6. Luster AD, Mechanisms of disease. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436–445.
  7. Justinich CJ, Kalafus D, Esposito P, Ricci A Jr, Sylvester FA, Hyams JS et al: Mucosal mast cells distinguish allergic from gastroesophageal reflux induced esophagitis. J Pediatr Gastroenterol Nutr 1996;23:342.

    External Resources

  8. Teitelbaum J, Fox V, Twarog F, Nurko S, Antonioli D, Gleich G et al: Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002;122:1216–1225.
  9. Mishra A, Hogan SP, Brandt EB, Rothenberg ME: An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001;107:83–90.
  10. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU: Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response. J Allergy Clin Immunol 2001;108:954–961.
  11. Gleich GJ, Kita H: Bronchial asthma: lessons from murine models. Proc Natl Acad Sci USA 1997;94:1101–1102.
  12. Akei HS, Mishra A, Blanchard C, Rothenberg ME: Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology 2005;129:985–994.
  13. Mishra A, Hogan SP, Brandt EB, Rothenberg ME: IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002;168:2464.
  14. Gupta SK, Fitzgerald JF, Roudratynk T, Hogenesch H: Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006;42:22–26.
  15. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP et al: Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006;116:536–547.
  16. Lucendo AJ, Navarro M, Comas C, Pascual JM, Burgos E, Santamaría L et al: Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology. An analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol 2006 (in press).
  17. Lucendo AJ, Carrión G, Navarro M, Pascual JM, González P, Castillo P et al: Eosinophilic esophagitis in adults: an emerging disease. Dig Dis Sci 2004;49:1884–1888.
  18. Adamko DJ, Odemuyiwa SO, Vethanayagan D, Moqbel R: The rise of the phoenix: the expanding role of the eosinophil in health and disease. Allergy 2005;60:13–22.
  19. Rothenberg ME, Mishra A, Brandt EB, Hogan SP: Gastrointestinal eosinophils. Immunol Rev 2001;179:139–155.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50